Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.

Hagop Kantarjian; Jean-Pierre J Issa; Craig S Rosenfeld; John M Bennett; Maher Albitar; John DiPersio; Virginia Klimek; James Slack; Carlos de Castro; Farhad Ravandi

doi:10.1002/cncr.21792

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.

Identifier:nobleid.org/w1/20260515/706CD44D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/706CD44D.svg?ark=w1%2F20260515%2F706CD44D)](https://nobleid.org/work/w1/20260515/706CD44D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.

Identifier:nobleid.org/w1/20260515/706CD44D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/706CD44D.svg?ark=w1%2F20260515%2F706CD44D)](https://nobleid.org/work/w1/20260515/706CD44D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work